Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Earnings
US: News
Health & Science
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Amgen Inc
Lennar Corp
Pultegroup Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Uber Technologies Inc
Chipotle Mexican Grill Inc
Merck & Co Inc
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
GE Vernova Inc
Fox Corp/ Class A
Micron Technology Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
Tesla Inc
Norfolk Southern Corp
Investing
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Companies
Breaking news
Biogen Inc
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Breaking News: Earnings
Health care industry
Business
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Health care industry
Business
Biogen Inc
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
US: News
Eli Lilly and Co
Health & Science
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Business News
Eisai Co Ltd
Business
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Jfrog Ltd
Markets
Kratos Defense and Security Solutions Inc
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Comcast Corp
Intel Corp
Li Auto Inc
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Eli Lilly and Co
US: News
Pharmaceuticals
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Health & Science
Biogen Inc
Health care industry
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
US: News
Earnings
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Tesla Inc
Airbnb Inc
Investing
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Companies
Biogen Inc
Business
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Biogen Inc
Business
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Warner Bros Discovery Inc
Economy
Business News
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Companies
Breaking news
Health care industry
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Business News
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Ford Motor Co
Market Insider
Markets
From
CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
United Parcel Service Inc
Earnings
Stock markets
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Health care industry
Business
Biogen Inc
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
5 Things to Know
Investing
Eli Lilly and Co
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
US: News
Eli Lilly and Co
Pharmaceuticals
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Social issues
US: News
Politics
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Companies
Health care industry
Business
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.